User:Crud muffins/sandbox/c

Cellink is a biotechnology startup that designs bio-inks and bioprinters for culturing different cell types. The company has ongoing collaborations with organizations including MedImmune, MIT and Takara Bio, and its printers are used for research at Harvard University, Merck, Novartis, the U.S. Army, Toyota, Johnson & Johnson and more.

History
Cellink was officially founded in 2016 by Erik Gatenholm and Héctor Martinez. They developed and sold the world's first universally compatible bio-ink to simplify bioprinting for academics and pharmaceutical companies who were, at that time, mixing their own biomaterial in-house. The company released its first bioprinter to test the market in 2015, and continued designing additional bio-inks to support more specialized applications in bioprinting.

Ten months after it was founded, Cellink was listed publicly on the Nasdaq. At its IPO, shares were oversubscribed by 1070 percent.

As of February 2019, the company's products are used by more than 600 labs in more than 50 countries.